Application Sponsors
ANDA 078203 | LEADING PHARMA LLC | |
Marketing Status
Prescription | 001 |
Prescription | 002 |
Prescription | 003 |
Application Products
001 | TABLET;ORAL | 0.5MG | 0 | LORAZEPAM | LORAZEPAM |
002 | TABLET;ORAL | 1MG | 0 | LORAZEPAM | LORAZEPAM |
003 | TABLET;ORAL | 2MG | 0 | LORAZEPAM | LORAZEPAM |
FDA Submissions
TE Codes
001 | Prescription | AB |
002 | Prescription | AB |
003 | Prescription | AB |
CDER Filings
LEADING PHARMA LLC
cder:Array
(
[0] => Array
(
[ApplNo] => 78203
[companyName] => LEADING PHARMA LLC
[docInserts] => ["",""]
[products] => [{"drugName":"LORAZEPAM","activeIngredients":"LORAZEPAM","strength":"0.5MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"LORAZEPAM","activeIngredients":"LORAZEPAM","strength":"1MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"LORAZEPAM","activeIngredients":"LORAZEPAM","strength":"2MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"LORAZEPAM","submission":"LORAZEPAM","actionType":"0.5MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"LORAZEPAM","submission":"LORAZEPAM","actionType":"1MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"LORAZEPAM","submission":"LORAZEPAM","actionType":"2MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)